The DefINe clinical trial has recently featured in the BBC. The article follows the first patient taking part in this trial, funded by LifeArc. The main aim of this study is to learn how well the oral study drug (deferiprone) works and how safe the study drug is compared with placebo, in patients with neuroferritinopathy.
The trial is still recruiting patients. If you would like to find out more about the trial, please click here.